Pfizer Stock (PFE) Today: 2026 Guidance Triggers Fresh Scrutiny—News, Forecasts, Analyst Targets and Dividend Outlook (Dec. 17, 2025)
Pfizer Inc. stock is back in the spotlight on Wednesday, December 17, 2025, as investors digest the drugmaker’s newly issued 2026 outlook, a revised 2025 revenue view, and a longer runway to sustained growth than some shareholders had hoped for. Shares were trading around the mid-$25 range today, following a sharp reaction to the guidance update earlier this week.
